Overview

SYMPOSIUM OVERVIEW

The 2026 New York Endovascular Summit (NYEVS) is a multidisciplinary conference focused on the diagnosis and treatment of Peripheral Vascular Disease. This 3-day conference, taking place from September 24-26, 2026, will feature different tracks: Non-Aortic PAD, Aortic, and Podiatry. The New York Endovascular Summit aims to provide an open platform for discussing new methods, technologies, and techniques for everyday solutions in the field of Endovascular Interventions. Our objective is to create an interdisciplinary forum and showcase the most effective approaches in managing peripheral artery disease (PAD).

This three-day symposium will bring together colleagues from various specialties across the country and the world, including experts in aortic and endovascular interventions, as well as leaders in nursing and podiatry. The symposium will focus on presenting concise and current information through a didactic interactive format, featuring live cases transmitted from top centers worldwide.

FOCUSED EDUCATION

The 2026 New York Endovascular Summit will focus on the diagnosis and treatment of complex Peripheral Arterial Disease (PAD), Chronic Limb-Threatening Ischemia (CLTI), carotid disease, and aortoiliac pathology, with live case transmissions designed to demonstrate the latest endovascular techniques, devices, and technologies. The program will highlight real-world clinical decision-making through a combination of expert lectures, debates, case reviews, and panel discussions addressing the most pressing controversies in endovascular therapy.

Educational sessions will explore evolving treatment algorithms and emerging data across the full spectrum of endovascular interventions, including vessel preparation strategies, atherectomy, drug-coated balloons, drug-eluting stents, bioabsorbable scaffold technologies, intravascular imaging, and thrombectomy approaches. The symposium will also highlight new and emerging therapies such as Percutaneous Deep Venous Arterialization (DVA), intravascular lithotripsy, and advanced revascularization techniques for complex PAD and CLTI.

The program features live case transmissions from leading international institutions, providing attendees with an opportunity to observe complex procedures performed by world-renowned operators while engaging in interactive discussion with faculty and panelists. Topics presented through these live demonstrations include complex aortoiliac interventions, common femoral artery disease, femoropopliteal disease, below-the-knee interventions, carotid disease management, and treatment strategies for CLTI.

NYEVS offers educational sessions tailored to a multidisciplinary audience including endovascular specialists, podiatrists, family physicians, nurses, technologists, and other allied healthcare professionals, with specialty-specific accreditation where applicable.

The summit will feature focused discussions on emerging therapies and treatment strategies in an interactive format with leading global experts, including:

• Chronic Limb-Threatening Ischemia (CLTI) Revascularization Strategies
• Advanced Imaging and the Role of IVUS in Peripheral Intervention
• Bioabsorbable and Drug-Eluting Endovascular Technologies
• Percutaneous Deep Venous Arterialization (DVA) for No-Option CLI
• Vessel Preparation Strategies Including Atherectomy and Lithotripsy
• Carotid Artery Disease Management and the Impact of CREST-2
• Emerging Data from Major Trials in Peripheral and Endovascular Medicine

TARGET AUDIENCE

The 2026 New York Endovascular Summit has been designed to meet the educational needs of:

• Vascular Surgeons
• Interventional Cardiologists
• Vascular Medicine Specialists
• Podiatrists and Wound Care Specialists
• Nurses and Cath Lab Technologists
• Other allied healthcare professionals involved in vascular care

EDUCATIONAL LEARNING OBJECTIVES

At the conclusion of this symposium, attendees should be able to:

• Discuss the indications, risks, and complications of interventional therapies used in the treatment of PAD, CLTI, and carotid disease.
• Implement contemporary approaches to peripheral vascular management including aortoiliac, femoropopliteal, below-the-knee, and carotid interventions based on current clinical evidence.
• Evaluate the role of emerging technologies such as drug-coated balloons, drug-eluting stents, bioabsorbable scaffolds, intravascular lithotripsy, and atherectomy devices in the management of PAD.
• Understand the role of advanced intravascular imaging such as IVUS in guiding procedural strategy and improving outcomes.
• Describe the clinical indications and procedural techniques for Percutaneous Deep Venous Arterialization (DVA) in patients with no-option CLTI.
• Interpret current and emerging data from major clinical trials influencing contemporary endovascular practice.
• Evaluate treatment strategies for carotid artery disease, including transfemoral stenting, TCAR, and surgical approaches.
• Apply evidence-based pharmacologic management strategies in patients with cardiovascular disease and peripheral artery disease.
• Recognize the importance of multidisciplinary collaboration in the treatment of complex vascular disease.